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We analyzed the U79-80 gene of human herpesvirus 6 (HHV-6), which is predicted to be a positional homolog of the
UL112-113 gene of human cytomegalovirus (HCMV). The U79-80 gene encoded a family of nuclear proteins of 36, 41, 44, and
59 kDa. These proteins had common amino termini and were generated by complex alternative splicing. Transcripts from
U79-80 appeared as early as 3 h postinfection and could be detected in the presence of phosphonoformate. U79-80 proteins
were seen as early as 8 h postinfection and could be detected in the presence of phosphonoformate but not in the presence
of cycloheximide combined with actinomycin D treatment. The U79-80 proteins were localized to the nucleus of infected cells,
where they were detected as a speckled or punctuate pattern. Moreover, the U79-80 proteins colocalized with the
components of the viral DNA replication machinery and appeared to distribute adjacent to or touching nuclear domain 10,
where viral DNA replication occurs. From the sequence analysis of genomic DNA, the predicted amino acid similarity
between U79-80 and UL112-113 was lower than between other genes, but the characteristics of the transcripts and proteins
encoded by U79-80 were similar to those of UL112-113. These results suggest that the U79-80 proteins have a role in viral
DNA replication and are functional homologues of the UL112-113 proteins. © 2000 Academic PressINTRODUCTION
Human herpesvirus 6 (HHV-6) was first isolated from
the peripheral blood lymphocytes of patients with lym-
phoproliferative disorders (Salahuddin et al., 1986). Sub-
sequently, similar viruses were isolated from patients
with acquired immunodeficiency syndrome (AIDS) (Jo-
sephs et al., 1986; Downing et al., 1987; Tedder et al.,
1987; Lopez et al., 1988). The virus was thereafter shown
to be ubiquitous in the healthy adult population, with
seropositivity rates in excess of 90% (Okuno et al., 1989;
Enders et al., 1990; Levy et al., 1990). The HHV-6 isolates
form at least two groups, which can be distinguished by
molecular and biological criteria. The isolates desig-
nated GS and U1102-like are called HHV-6 variant A
(HHV-6A), whereas Z29-like viruses are termed HHV-6
variant B (HHV-6B) (Ablashi et al., 1993).
Primary infection with HHV-6B is clearly associated
with a childhood disease, exanthem subitum (Yamanishi
et al., 1988), whereas the pathological role of HHV-6A
remains to be determined. In immunosuppressed pa-
tients, such as those with AIDS (Knox and Carrigan, 1995;
Kositanont et al., 1999), leukemia (Drobyski et al., 1993;
Appleton et al., 1995; Cone et al., 1999), or transplants
1 To whom reprint requests should be addressed at Department of
icrobiology, Osaka University Medical School, 2-2 Yamada-oka, Suita,
saka 565-0871, Japan. Fax: 81-6-6879-3329. E-mail: yamanisi@micro.
ed.osaka-u.ac.jp.
307(Okuno et al., 1990; Yoshikawa et al., 1992; Singh et al.,
1997), either primary infection or reactivation is patho-
logically significant.
HHV-6 has a double-stranded DNA genome of 161 kbp
consisting of a 141-kbp unique region flanked by 10-kbp
direct repeats (Martin et al., 1991; Lindquester et al.,
1997). HHV-6, along with human herpesvirus 7 (HHV-7), is
classified as a member of the betaherpesvirus subfamily,
in the Roseolovirus genus (Pringle, 1998). These viruses
share extensive domains of similar genetic organization
with other betaherpesviruses such as human cytomeg-
alovirus (HCMV) (Martin et al., 1991; Nicholas, 1994;
Nicholas and Martin, 1994; Gompels et al., 1995;
Lindquester et al., 1997). The genomic organizations of
the unique long region of HHV-6 and HCMV are largely
colinear (Efstathiou et al., 1992; Gompels et al., 1995).
The U79-80 gene of HHV-6 is predicted to be a positional
homolog of HCMV UL112-113, but the predicted amino
acid similarity between their proteins is considerably
lower than that between HCMV and other HHV-6 genes
(Nicholas, 1994; Gompels et al., 1995). In particular, no
similarity was detected between U79 and UL112 (Nich-
olas, 1994; Gompels et al., 1995). It was speculated that
the functions of the U79-80 gene products might be
different from the HCMV UL112-113 gene products (Nich-
olas, 1994). Interestingly, even among betaherpesvi-
ruses, the similarity of the predicted amino acid se-
quences in the U79-80 region was relatively lower than
for the other genes, not only when HHV-7 and HHV-6
0042-6822/00 $35.00
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308 TANIGUCHI ET AL.were compared but also when HHV-6A and HHV-6B
were compared (Nicholas, 1996; Megaw et al., 1998;
ominguez et al., 1999; Isegawa et al., 1999). Thus, there
ppears to be considerable divergence among these
etaherpesviruses at this locus.
The role of UL112-113 in HCMV has been extensively
tudied but is still unclear. The UL112-113 gene products
re not essential for viral DNA replication in vitro system
ut are required for the efficient replication of viral DNA
Pari and Anders, 1993; Pari et al., 1993; Sarisky and
ayward, 1996; Yamamoto et al., 1998). It has been re-
orted that the viral replication components are assem-
led at subnuclear sites defined by UL112-113 (Iwayama
t al., 1994; Penfold and Mocarski, 1997; Yamamoto et al.,
998). The UL112-113 gene of HCMV encodes a family of
uclear phosphoproteins of 34, 43, 50, and 84 kDa, and
elongs to the early antigen class (Staprans and Spector,
986; Wright et al., 1988; Wright and Spector, 1989;
wayama et al., 1994). These four proteins have common
mino termini and are generated by complex alternative
plicing. Recently, HCMV UL112-113 gene products were
ound to transactivate the UL54 promoter in cooperation
ith major immediate-early (MIE) proteins and were
hown to be required, in cooperation with other viral
roteins, for the expression of viral genes involved in
eplication (Kerry et al., 1996; Li et al., 1999).
However, in the case of HHV-6, little is known about
he structure and function of the U79-80 gene. In this
tudy, we investigated the transcripts and proteins en-
oded by U79-80 gene and determined the localization of
hese proteins in HHV-6-infected cells.
RESULTS
tructure of transcripts and expression of proteins
ncoded in U79-80
To identify transcripts encoded by the U79-80 gene,
DNA libraries were screened using a genomic DNA
ragment containing U79 as the probe. For a random-
rimed cDNA library, of approximately 5000 colonies
creened, 35 were positive; 24 positive clones were
dentified using an oligo(dT)-primed cDNA library. To
etermine the structure of the transcripts encoded by the
79-80 gene of HHV-6, the cDNA clones from the
ligo(dT)-primed library were sequenced. Depending on
FIG. 1. Structure of transcripts. DNA sequences at the splicing jun
encoded in U79-80 of HHV-6 deduced from cDNA sequences. The op
presented above. Arrowheads indicate the ATG start codon at nt 121322
umbered according to Isegawa et al. (1999).. (B) Genomic DNA sequ
onor-acceptor sequences. (C) Western blot analysis of transiently exp
rotein expression in cells transfected with a genomic DNA fragment
, transfected with pSTY-09; and 7, 2, 27, and 37 indicate the transfected cDN
resented in (A). *Specific proteins detected in infected cells by an antibodyhe splicing patterns, cDNAs were classified into four
roups (Fig. 1A). Two splicing events were common to all
our groups of transcripts: splicing within the 59-noncod-
ng region (nt 121212 to nt 121317) and within U79 (nt
21952 to nt 122049). The difference in splicing patterns
ccurred in the way the U79 sequence was spliced to the
80 sequence, where complex alternative splicing pat-
erns were found. The sequences at the splicing junc-
ions were confirmed by amplifying the fragments con-
aining the splicing junctions by RT–PCR and sequencing
hem (Fig. 1A). The DNA sequences of the donor and
cceptor sites of the splicing are listed in Fig. 1B. The
plicing donor and acceptor sites were well-conserved
onsensus sequences (Fig. 1B). The four types of tran-
cripts appeared to be generated from the combination
f these donor-acceptor sites.
For the tentative mapping of the 59 end of the tran-
cripts, the start position of the cDNAs was determined
y sequencing the cDNA clones isolated from the ran-
om-primed library. Of the 21 clones sequenced, 7
tarted at nt 121154, but 5 started from upstream of that
oint and 9 started downstream of it (Table 1). To more
recisely map the 59 end of these transcripts, 59 rapid
mplification of cDNA ends (RACE) analysis was carried
ut using poly(A)1 RNA harvested at 24 h postinfection
(p.i.). Of 7 clones sequenced after TA cloning, 5 had their
59 end at nt 121140. As described below, within 1 kb
upstream of the U79 open reading frame, only one TATA
box-like sequence was found, at nt 121111–121116.
These results suggested that nt 121140 is most likely to
be the 59 end of these transcripts (Table 1). A TATA
box-like sequence (ATAAAA; nt 121111–121116) was
found 29 bp upstream of the putative start site (nt
121140). These four transcripts consisted of four exons,
and first two exons were common to all transcripts. The
first exon appeared to be untranslated, and the ATG
sequence at nt 121322, located within the second exon,
initiates the open reading frames. The coding frame and
sequences in fourth exon were different among those
transcripts, and the position of stop codon was also
different.
The 39 ends of these transcripts were also mapped
tentatively from the sequences of the cDNA clones gen-
erated by the oligo(dT)-primed library. Of the 15 clones
sequenced, 5 had their 39 end at nt 123071 and 4 were at
and the expression of U79-80 proteins. (A) Structures of transcripts
ing frames predicted by the analysis of genomic DNA sequence are
frame stop codons for each transcript. DNA sequence coordinates are
encompassing the splicing junction were compared with consensus
U79-80 proteins and proteins expressed in HHV-6-infected cells. The
9) is also presented. M indicates mock-infected or mock-transfected;ctions
en read
. F, In-
ences
ressed
(pSTY-0A expression plasmids that contain the individual cDNA sequences
against the common amino terminus of these proteins.
309ANALYSIS OF U79-80 GENE OF HHV-6
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310 TANIGUCHI ET AL.nt 123095 (Table 1), with the others distributed between
123058 and 123096. Within the 39-untranslated region of
the genomic DNA sequence, three well-conserved poly-
adenylation signals (AATAAA) were found, at nt 122495,
123038, and 123070. The last two polyadenylation sites
were used preferentially.
From each type of transcript, the representative
cDNA clone that was expected to encode the full-
length mRNA was selected, and the insert was re-
cloned into a expression vector (pcDNA 3.1). These
constructs were transfected into COS-7 cells, and the
proteins were analyzed by immunoblotting with an
antibody against the common amino-terminal peptide
of these proteins. The genomic clone generated four
proteins, as found in HHV-6-infected MT-4 cells at 48 h
p.i. Clone 7, which encoded U79, generated only the
36-kDa protein. Clone 2, which extended from U79 to
TABLE 1
Temporal Mapping of 59-End and 39-End
of Transcripts Encoded in U79-80
nt at 59-end Frequency
apping of 59-end
1) Position of 59-end in cDNA clones
120932 1
120934 1
121012 1
121152 2
121154 7
121155 1
121158 1
121160 1
121161 1
121163 3
121164 1
121164 1
Total clones sequenced 21
2) 59-RACE
121140 5
121175 2
Total clones sequenced 7
apping of 39-end
Position of 39-end in cDNA clones
123058 2
123061 1
123071 5
123072 1
123080 1
123095 4
123096 1
Total clones sequenced 15
DNA sequence coordinates are numbered according to Isegawa et
l. (1999).U80 with a deletion from nt 122248 to nt 122603,
encoded only the 41-kDa protein. Clone 27, which hada deletion from nt 122168 to nt 122603, encoded only
the 44-kDa protein. Finally, clone 37, which had a
deletion from nt 122248 to nt 122331, generated a
59-kDa and a 44-kDa protein, which probably arose
from a secondary splicing event that occurred after
transfection (Fig. 1C). The predicted molecular mass
and number of amino acid (aa) residues from the
cDNA sequences were 30 kDa (259 aa) for 7, 33 kDa
(282 aa) for 2, 37 kDa (322 aa) for 27, and 55 kDa (480
aa) for 37. These data agreed well with the molecular
masses detected with SDS–PAGE, and there appeared
to be no major posttranslational modification of these
proteins.
Expression of U79-80 mRNAs in infected cells
Herpesvirus gene expression can be classified as im-
mediate-early (IE), early, and late (Mocarski, 1996). The IE
gene expression is independent of de novo gene expres-
sion and initiated immediately on virus entry. Therefore,
cycloheximide (CHX), a translation inhibitor, will have no
effect on the expression of IE genes but will inhibit IE-
dependent viral early and late gene expression. The ex-
pression of early genes is independent of viral DNA repli-
cation, and early genes are involved in gene regulation and
DNA replication. The late genes are dependent on viral
DNA replication and encode structural proteins. An inhibitor
of viral DNA replication, phosphonoformate (PFA), will in-
hibit the late gene expression but will have no effect on the
expression of IE and early genes.
To determine whether the transcripts encoded by
U79-80 gene belonged to the IE, early, or late class of
mRNAs, total RNA was prepared at 8 h p.i. in the pres-
ence of CHX (100 mg/ml) or at 24 h p.i. in the presence of
PFA (400 mg/ml). To analyze the time course of the
xpression of these transcripts, total RNA was also pre-
ared at 4, 8, and 48 h p.i. in the absence of any inhibitor.
The expression of the transcripts was initially analyzed
y Northern blot hybridization. Only the major 1.5-kb
ranscript was detected at 8 h p.i. in either the presence
f PFA or the absence of inhibitor (Fig. 2). The amount of
his transcript increased as the infection progressed.
owever, no transcript was detected in the presence of
HX. As indicated by the sequence analysis of the cDNA
lones (Fig. 1A), the sizes of the four types of transcript
ere too similar to distinguish them using Northern blot
nalysis, so they were then detected using RT–PCR.
rimers containing introns were chosen so that the four
ypes of transcripts could be distinguished from one
nother and from contaminating genomic DNA (Fig. 3A).
oly(A)1 RNA was extracted from infected cells at 4, 8,
and 18 h p.i. and reverse-transcribed after priming with
oligo(dT). The resulting cDNA was analyzed by PCR. All
four types of transcripts were detected as early as 4 h
p.i., and no signal was detected in the samples without
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311ANALYSIS OF U79-80 GENE OF HHV-6RT (Fig. 3B). The expected sizes of the fragments ampli-
fied from the fully spliced transcripts using this primer
set were 623 bp for 7, 431 bp for 2, 351 bp for 27, and 701
bp for 37. This primer set was designed to encompass
two introns, and minor fragments that had not been
spliced were also detected just above the major frag-
ments after electrophoresis.
To determine the class of the four types of transcript,
poly(A)1 RNA was extracted from HHV-6- infected or
ock-infected cells at 3 h p.i. in the absence of inhibitor,
t 8 h p.i. in the presence of CHX (100 mg/ml), and at 24 h
p.i. in the presence of PFA (400 mg/ml). The expression of
the transcripts was detected by RT–PCR as described
above. As early as 3 h p.i., all four types of transcripts
were detected in the absence of inhibitor. Even in the
presence of CHX or PFA, these transcripts were detected
by RT–PCR, but the expression level in the presence of
CHX was relatively low (Fig. 4). Detection of a small
amount of transcripts only by RT–PCR in the presence of
CHX may reflect the possibility that these transcripts
were carryovers from virus inoculum or leaky transcripts
under these condition. These results then suggested that
FIG. 2. Northern blot analysis for expression of the U79-80 tran-
scripts in HHV-6-infected cells. MT-4 cells were infected with HHV-6
in the presence of CHX (100 mg/ml) or PFA (400 mg/ml) and in the
bsence of inhibitor. Total RNA was harvested at 8 h p.i. in the
resence of CHX, at 4, 8, and 24 h p.i. in the presence of PFA, and
t 4, 8, and 48 h p.i. without inhibitor. (A) Autoradiogram showing
ybridization with a DNA fragment encoding U79. Arrowheads indi-
ate the position of cellular 28S and 18S ribosomal RNAs. M indi-
ates mock-infected; I, HHV-6 infected. (B) Ethidium bromide-
tained gel used to estimate RNA amounts and quality, before
ransfer of RNA to membrane.the transcripts encoded by U79-80 gene were most likely
to be an early transcripts.
6
pExpression pattern of U79-80 proteins in infected
cells
To investigate the expression pattern of the proteins
encoded by U79-80, infected cells were harvested at 3, 8,
16, 24, and 48 h p.i. and analyzed by immunoblotting with
an antibody against the common amino-terminal peptide
of these proteins (Fig. 5A). Of the four proteins, the
36-kDa protein was detected as early as 8 h p.i., and its
expression level was the highest at all time points tested.
The expression of the 36-kDa protein increased as the
infection progressed. The 41- and 44-kDa proteins were
also detected at 8 h p.i., and their expression also in-
creased as infection progressed. The 59-kDa protein
was first detected at 48 h p.i., and its expression level
was lower than that of the others. At 48 h p.i., lower-
molecular-weight proteins were also detected, but these
were likely to be degradation products. To identify the
subcellular distribution of these proteins, infected cells
were harvested at 48 h p.i. and divided into two equal
fractions. One fraction was used to generate whole-cell
lysate, and the other was separated into nuclear and
cytoplasmic fractions as described in Materials and
Methods. These samples were analyzed by Western
blotting. The four proteins were found predominantly in
the nuclear fraction (Fig. 5A).
To determine the class of proteins, HHV-6-infected and
mock-infected cells were harvested at 48 h p.i. in the
absence of inhibitor or at 48 h p.i. in the presence of PFA
(400 mg/ml). Cells were also harvested after 5 h in the
presence of CHX (100 mg/ml), followed by an additional
-h incubation in medium containing 10 mg/ml actinomy-
in D (Act-D), which inhibits further transcription while
ermitting translation of transcripts that accumulated in
he presence of CHX. None of the proteins were detected
n the presence of CHX combined with Act-D. The 36-,
1-, and 44-kDa proteins, but not the 59-kDa protein,
ere detected in the presence of PFA (Fig. 5B). These
esults suggested that of four proteins encoded in U79-
0, three (36, 41, and 44 kDa) proteins belonged to early
lass and one (59 kDa) belonged to late class.
osttranslational modification of U79-80 proteins
To determine the posttranslational modification of pro-
eins encoded within the U79-80 gene, each cDNA was
ranscribed and translated in vitro. The translation prod-
cts were compared with the proteins immunoprecipi-
ated from HHV-6-infected cells using an antibody
gainst the common amino-terminal peptide of these
roteins or an antibody against the unique carboxyl-
erminal fragment of 44-kDa protein encoded by cDNA
7. Each protein translated in vitro comigrated with the
ntigens in the HHV-6-infected cells on SDS–PAGE (Fig.
). These results suggested that there was no major
osttranslational modification of the proteins encoded by
ac ent of
f re sep
312 TANIGUCHI ET AL.the U79-80 gene. We also tested whether the U79-80
proteins were phosphorylated by labeling the HHV-6-
infected cells with 32P-orthophosphate, followed by im-
munoprecipitation. However, no specific phosphorylation
of U79-80 proteins was found (data not shown).
Localization of individual U79-80 proteins in
transfected cells
The localization of the individual U79-80 proteins in
FIG. 3. RT–PCR analysis for the expression time course of U79-80 tr
nalysis. The primer pair was designed to encompass two introns. DN
Detection of the transcripts by RT–PCR. RNA was extracted at 4, 8, an
reverse-transcriptase, and aliquots were amplified by PCR. N.C., negat
ontrol for RT–PCR where a plasmid containing a genomic DNA fragm
or DNA fragments. The fx174/HaeIII digest and l/Eco T14 I digest we293T cells transfected with an expression vector encod-
ing each cDNA was investigated. The U79-80 proteins intransfected cells were detected by indirect immunofluo-
rescence assay using an antibody against the common
amino-terminal peptide of these proteins. All four pro-
teins localized to the nucleus, but the distribution of
antigens within the nucleus differed (Fig. 7). The 41-kDa
protein encoded by cDNA 2 formed irregularly shaped
foci in the nucleus and associated with the nuclear
membrane (Figs. 7a and 7b). The 36-kDa protein en-
coded by cDNA 7, which was the predominant protein
ts in HHV-6-infected cells. (A) Position of primer pair used for RT–PCR
ence coordinates are numbered according to Isegawa et al. (1999). (B)
p.i. First-strand cDNA was synthesized in the presence or absence of
trol for RT–PCR where dH2O was added as the template; P.C., positive
HHV-6 (pSTY-09) was used as the template. M indicates size markers
arated in parallel lanes. *Specific PCR products.anscrip
A sequ
d 18 h
ive conexpressed in infected cells, was detected as irregularly
speckled foci in the nucleus and was associated with the
p
D
m
313ANALYSIS OF U79-80 GENE OF HHV-6nuclear membrane. However, their distribution within the
nucleus appeared to be different from that of cDNA 2
(Figs. 7c and 7d). The 44-kDa protein encoded by cDNA
27 showed many punctate foci and was distributed
evenly in the nucleus (Figs. 7e and 7f). The 59- and
44-kDa proteins encoded by cDNA 37 formed small,
punctate foci compared with cDNA 27, and the number of
foci in the nucleus was larger than that seen when
cDNA27 was expressed (Figs. 7g and 7h). Cells trans-
fected with expression vector containing the genomic
DNA fragment encoding the U79-80 region expressed all
four proteins with the same pattern as seen in infected
cells (Fig. 1B), and the localization of the U79-80 gene
products in these cells was similar, but not identical, to
that of the protein encoded by cDNA 7, which was the
most strongly expressed (Figs. 7i and 7j). The distribution
pattern of U79-80 proteins in cells transfected with
genomic DNA fragment reflected a mixture of the distri-
bution pattern of each proteins. The distribution patterns
of U79-80 proteins in HHV-6-infected cells (Figs. 8a, 8d,
and 8g) were most similar to that of the proteins trans-
fected by genomic DNA fragment.
Colocalization of U79-80 proteins in infected cells
with other viral and cellular proteins
It was reported that the products from the UL112-113
FIG. 4. RT–PCR analysis of the expression of U79-80 transcripts
under IE and early conditions. RNA was extracted at 3 h p.i. in the
absence of inhibitor, at 8 h p.i. in the presence of CHX, and at 24 h p.i.
in the presence of PFA. First-strand cDNA was synthesized in the
presence or absence of reverse-transcriptase, and aliquots were am-
plified by PCR. M indicates mock-infected; I, Infected; N.C., negative
control for RT–PCR, where dH2O was added as the template; and P.C.,
ositive control for RT–PCR, where a plasmid containing the genomic
NA fragment of HHV-6 (pSTY-09) was used as the template. M, Size
arkers for DNA fragments. The fx174/HaeIII digest and l/Eco T14 I
digest were separated in parallel lanes. *Specific PCR products.gene of HCMV interact with viral DNA replication ma-
chinery (Penfold and Mocarski, 1997) and that a cellularfactor called ND-10 associates with viral replication pro-
teins (Ishov and Maul, 1996). To investigate this possi-
bility with the U79-80 proteins, we tested DNA polymer-
ase processivity factor (U27), major DNA binding protein
(U41), and cellular PML antigen in a colocalization ex-
FIG. 5. Expression time course of U79-80 proteins in HHV-6-infected
cells and their subcellular localization. (A) Detection of proteins en-
coded by U79-80 at various time points after infection, and biochemical
analysis of their subcellular localization by Western blot. HHV-6-in-
fected MT-4 cells were harvested at the indicated times after infection
and analyzed by Western blotting with an antibody against the common
amino-terminal peptide of these proteins. HHV-6 infected cells har-
vested at 48 h p.i. were separated into whole, nuclear, and cytoplasmic
fractions, as described in Materials and Methods. Each fraction was
subjected to SDS–PAGE and analyzed by Western blotting. W indicates
whole-cell lysate; N, nuclear fraction; and C, cytoplasmic fraction. (B)
The class of protein expression encoded in U79-80. Expressions of
U79-80 proteins were tested in infected or mock-infected cells under
the IE condition (CHX), the early condition (PFA), or the late condition
(Non; no inhibitor). Cell lysates were fractionated by SDS–PAGE and
analyzed by Western blotting using an antibody against the common
amino-terminal peptide of these proteins. *Specific proteins detected in
infected cells by an antibody against the common amino terminus of
these proteins.
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314 TANIGUCHI ET AL.periment with the U79-80 proteins in infected cells at
24 h p.i. The U79-80 proteins localized within the nucleus
as punctate foci and colocalized with the U27 (Figs.
8d–8f) and U41 (Figs. 8g–8i) gene products of HHV-6.
However, the U79-80 proteins and the ND-10 did not
always overlap perfectly, suggesting that in a fraction of
infected cells, ND-10 and U79-80 proteins are localized
to juxtaposed or partially overlapping nuclear domains
(Figs. 8a–8c). In the case of HCMV, it was also reported
that the UL112-113 proteins accumulated in viral DNA
replication compartments that initiated from the periph-
ery of ND-10 (Ahn et al., 1999).
DISCUSSION
In this study, we demonstrated that the U79-80 gene
as a similar pattern of transcription and protein expres-
ion as the UL112-113 gene of HCMV. From the se-
uences of cDNAs encoding U79-80, all of the mRNAs
how a complex structure with a common 59 end and
nternal exons and alternative 39 exons. The U79-80 gene
ncoded four proteins that arise from complex alterna-
ive splicing, as do those encoded by the HCMV UL112-
13 gene, but all of their molecular masses were different
rom those of the proteins encoded by HCMV (Wright et
l., 1988). The precise splicing patterns of HHV-6 were
lso slightly different from those of HCMV. In the UL112-
13 gene, the 34-kDa protein is encoded by an unspliced
ranscript, the 84-kDa protein is encoded by a transcript
hat was spliced once, and the other two proteins are
FIG. 6. Comparison of the U79-80 proteins synthesized in infected
cells and translated in vitro. HHV-6-infected or mock-infected MT-4
cells were labeled with 35S-methionine and immunoprecipitated with a
abbit polyclonal antibody against the common amino-terminal peptide
f the U79-80 proteins or with an antibody against the unique carboxyl-
erminal peptide of the 44-kDa U79-80 protein encoded by cDNA clone
7. Proteins were fractionated by SDS–PAGE. In vitro transcribed and
ranslated proteins from cDNAs were also separated in parallel lanes.
Specific proteins encoded in U79-80.ncoded by transcripts that were spliced twice (Wright
nd Spector, 1989). In the case of HHV-6, all four proteins
U
iere encoded by fully spliced transcripts, because well-
onserved consensus sequences existed within the
plicing sites. Megaw et al. (1998) predicted the splicing
onor and acceptor sites within the U79-80 gene of
HV-6 strain U1102; these two predicted sites corre-
pond to splicing within U79 (nt 121952–122049) and the
plicing of U79 to U80 (nt 122248–122331) for HHV-6
train HST. Although the amino acid similarity of the
79-80 region between U1102 and HST is relatively
ower than that of the other regions (Dominguez et al.,
999; Isegawa et al., 1999), the nucleotide sequences at
he splicing sites were almost identical. Thus, the splic-
ng pattern of the U79-80 region in strain U1102 also may
e complex.
In the presence of CHX, we could detect a small
mount of transcripts encoded by U79-80 only by RT–
CR; however, we could not detect the transcripts by
orthern blot analysis. Also, we could not detect U79-80
roteins by Western blotting in the presence of CHX
ollowed by Act-D treatment. These results suggested
hat the transcripts encoded within U79-80 are not likely
o be IE transcripts but belonged to early class.
In the presence of PFA, all four transcripts were de-
ected by RT–PCR, but although the 36-, 41-, and 44-kDa
roteins were expressed, the 59-kDa protein was not
etectable. A similar result was reported for HCMV, in
hat the transcripts encoded by the UL112-113 gene were
etected in the presence of PAA, but one (pp50) of the
our proteins was not detectable (Wright and Spector,
989). Moreover, the relative amounts of the transcripts
ncoding the 59-, 36-, and 41-kDa proteins of HHV-6
ere almost the same and higher than the transcript
ncoding the 44-kDa protein at 4, 8, and 18 h p.i. by
T–PCR, but the expression levels of the proteins were
ot correlated with the abundance of the transcripts. As
uggested for the UL112-113 gene of HCMV, there may
xist a posttranscriptional regulation of protein synthesis
or these transcripts (Wright and Spector, 1989). It has
een reported that proteins encoded by the UL112-113
ene of HCMV are phosphorylated (Wright et al., 1988),
ut we could not detect specific phosphorylation of the
79-80 gene products. The lower similarity of amino acid
equence between U79-80 and UL112-113, especially
etween U79 and UL112, may be responsible for the
ifferences between HHV-6 and HCMV described above.
The subcellular localization of the U79-80 gene prod-
cts in infected cells was mainly to the nucleus, where
hey were detected as speckled or punctuate patterns in
nfected cells. These patterns are very similar to those of
he UL112-113 gene products of HCMV in infected cells
Iwayama et al., 1994; Penfold and Mocarski, 1997;
amamoto et al., 1998). We also tested the subcellular
ocalization of the individual proteins encoded by the
79-80 gene in transfected cells. All four proteins local-
zed to the nucleus, but their intranuclear distributions
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presses all four proteins encoded by U79-80. Original magnification,
4003 for a, c, e, g, and i and 6303 for b, d, f, h, and j.
315ANALYSIS OF U79-80 GENE OF HHV-6differed. Because these proteins have a common amino-
terminal region (aa 1–251) and different carboxyl-termi-
nal regions, these results suggest that the nuclear local-
ization signal (NLS) may exist within the common amino
terminal region and that the intranuclear distribution is
regulated by the carboxyl-terminal region of these pro-
teins. Computer-aided analysis of the amino acid se-
quence identified six putative NLSs within the common
amino-terminal region (aa 1–251). RKKH (aa 157–160),
HRKR (aa 164–167), and PPKEKRQK (aa 212–219) are
classic NLSs, and KKHDDEHRKRSGKQKEK (aa 158–174),
KKKEDEKLKQEEKKRND (aa 158–174), and KRPDKK-
DEFDEPPKEKR (aa 201–217) are bipartite NLSs (Gorlich
and Mattaj, 1996). It is, however, still unclear what se-
quences in the carboxyl-terminal region are responsible
for the intranuclear distribution of these proteins, al-
though these differences may indicate different functions
for the four proteins. In the case of HCMV, of the four
proteins encoded by UL112-113, three (pp43, pp50, and
pp84) have a common NLS and transcriptional activation
domain, but pp34 does not have either of these domains
(Li et al., 1999). In addition, in cells transfected with an
expression plasmid containing cDNA for each of the
proteins individually, although pp43 was detected as a
punctuate pattern localized to the nucleus, pp34 local-
ized mainly to the cytoplasm (Li et al., 1999). These
results also suggest that the individual proteins encoded
by UL112-113 gene may have different functions in in-
fected cells. The subcellular localization pattern of
U79-80 in infected cells was most similar to that of the
proteins transfected by genomic DNA fragment, and
cells transfected with expression vector containing the
genomic DNA fragment encoding the U79-80 region ex-
pressed all four proteins with the same pattern as seen
in infected cells. These results suggested that the local-
ization pattern of U79-80 proteins in infected cells may
be a mixture of the distribution pattern of each individual
proteins, and the localization of U79-80 proteins was
determined without other viral proteins.
Several viral DNA replication proteins of human her-
pesviruses have been shown to colocalize to intranu-
clear structures, named the prereplication site and rep-
lication compartments, before and during viral infection
with HSV (de Bruyn Kops and Knipe, 1988, 1994; Good-
rich et al., 1990), EBV (Kiehl and Dorsky, 1991; Takagi et
al., 1991), and HCMV (Iwayama et al., 1994; Penfold and
Mocarski, 1997; Yamamoto et al., 1998). The HHV-6 pro-
teins reported here localized to similar structures. The
ND-10 structures, also known as POD (promyelocytic
oncogenic domains), are intranuclear domains identified
by the presence of one or more antigens, including the
tumor suppresser promyelocytic leukemia protein (PML)
(Lamond and Earnshaw, 1998). Components of ND-10FIG. 7. Localization of individual U79-80 proteins in 293T cells after
ransfection. Expression plasmids encoding the individual U79-80
roteins and a genomic DNA fragment containing the U79-80 region
ere transfected into 293T cells. At 24 h posttransfection, the
istribution of the individual proteins was detected using a rabbit
olyclonal antibody raised against the common amino-terminal pep-
ide of the U79-80 proteins. (a and b) Cells transfected with cDNA 2,
hich encodes the 41-kDa protein of U79-80. (c and d) Cells trans-
ected with cDNA7, which encodes the 36-kDa protein of U79-80. (e
nd f) Cells transfected with cDNA 27, which encodes the 44-kDa
rotein of U79-80. (g and h) Cells transfected with cDNA 37, which
ncodes the 59- and 44-kDa proteins of U79-80. (i and j) Cells
ransfected with the genomic DNA fragment (pSTY-09), which ex-
are recruited into the HSV replication compartments
(Burkham et al., 1998). Moreover, adenovirus, HSV-1, and
t
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316 TANIGUCHI ET AL.SV40 DNAs replicate in intranuclear sites that are lo-
cated adjacent to ND-10 (Ishov and Maul, 1996). The
U79-80 gene products of HHV-6 and ND-10 in infected
cells did not completely colocalize in the present study.
However, in a fraction of the infected cells, the U79-80
proteins were located adjacent to ND-10 (Figs. 8a–8c).
Moreover, the U79-80 proteins colocalized with compo-
nents of the viral DNA replication machinery (DNA poly-
merase processivity factor and major DNA binding pro-
tein) in HHV-6-infected cells. These data suggest that the
U79-80 gene products of HHV-6 have a role in viral DNA
replication and are functional homologues of the UL112-
113 gene products of HCMV.
MATERIALS AND METHODS
Virus and cells
FIG. 8. Colocalization of U79-80 proteins with components of the vira
arvested and fixed in acetone at 220°C. The cells were incubated w
U79-80 proteins (a, d, and g) and a mouse monoclonal antibody agains
detected with FITC-conjugated secondary antibody, and the mouse m
rhodamine. The merged images are shown on the right (c, f, and g). CUmbilical cord blood mononuclear cells (CBMCs)
were isolated by density gradient centrifugation using
2
FFicoll-Conray solution. The cells were stimulated for 2–3
days with 5 mg/ml of phytohemagglutinin in RPMI 1640
containing 10% fetal bovine serum (FBS). HHV-6 strain
HST was propagated in the stimulated CBMCs. To pre-
pare virus stock, HHV-6-infected CBMCs was cultured
until more than 80% of the cells showed cytopathic effect,
and the culture of infected cells was disrupted by three
freeze-thaw cycles. The debris was removed by centrif-
ugation at 4°C for 20 min at 3000 g, and the supernatant
was stored at 280°C. For the infection of MT-4 cells with
HHV-6, MT-4 cells were washed twice with PBS, and 107
cells were suspended in 1 ml of virus stock solution. The
cells were then centrifuged at 1500 g for 30 min at 37°C
o enhance the efficiency of infection and cultured in
PMI 1640 containing 10% FBS. MT-4 cells were main-
ained in RPMI 1640 containing 10% FBS. COS-7 and
ation machinery or ND-10. HHV-6-infected MT-4 cells at 24 h p.i. were
abbit polyclonal antibody against common amino-terminal peptide of
0 (b), HHV-6 U27 (e), or HHV-6 U41 (h). The localization of U79-80 was
onal antibody was visualized with a secondary antibody coupled to
zation of the proteins is indicated in yellow.l replic
ith a r
t ND-193T cells were maintained in DMEM containing 10%
BS.
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317ANALYSIS OF U79-80 GENE OF HHV-6Construction of cDNA libraries and screening
Poly(A)1 RNA from HHV-6-infected CBMC at 48 h p.i.
as used as the template for cDNA synthesis. Starting
ith 5 mg of poly(A)1 RNA, cDNAs were synthesized with
100 ng of random primer or 1 mg of oligo(dT) primer using
the Superscript Choice System for cDNA synthesis kit
(GIBCO BRL, Grand Island, NY). The synthesized cDNAs
were inserted into the plasmid vector pGAD424 (Clon-
tech, Palo Alto, CA) and introduced into DH5a Esche-
richia coli by electroporation. cDNA clones were
screened with a 32P-labeled PstI–KpnI fragment of pSTY-
9, which contains the U79 open reading frame (Kosuge
t al., 1997).
eneration of antiserum
To detect the U79-80 proteins on Western blots and
ndirect immunofluorescence assay, antibodies were
aised to a common amino-terminal peptide and the
arboxyl-terminal peptide of the 44-kDa U79-80 protein
ncoded by cDNA clone 27. A DNA fragment from posi-
ion 121553–121954 encoding 133 aa of the common
mino-terminal region of U79 was isolated by PCR using
rimers containing a BamHI site and cloned in-frame into
he BamHI site of the pGEX-3X bacterial expression vec-
or (Pharmacia, Piscataway, NJ). The expression of the
ST-U79 fusion protein was induced in E. coli BL21 with
.5 mM isopropyl-b-D-thiogalacto-pyranoside (IPTG), af-
finity-purified with glutathione–Sepharose FF (Pharma-
cia), and used to immunize a rabbit. A DNA fragment
from position 122605–122849 that encodes 71 aa of the
carboxyl-terminal region of one of the U79-80 proteins
was isolated by PCR. This fragment was also introduced
into pGEX-3X, and the GST-U80 (27) fusion protein was
purified as above and used for immunization. The rabbits
were first immunized with 100 mg of fusion protein in
Freund’s complete adjuvant and subsequently boosted
with 100 mg of fusion protein in Freund’s incomplete
adjuvant at 2-week intervals. Two weeks after the fifth
injection, sera were collected.
RNA preparation and Northern blotting
Total RNA was extracted from 1 3 107 cells of HHV-6-
infected or mock-infected MT-4 cells by the acid guani-
dinium thiocyanate-phenol-chloroform method and
treated with 10 U of RNase-free DNase I (Boehringer-
Mannheim Biochemicals, Indianapolis, IN). For Northern
blot hybridization, 2 mg of total RNA was fractionated on
a 1% agarose gel containing formaldehyde and trans-
ferred onto a nylon membrane (Hybond-N; Amersham).
The membrane was baked at 80°C for 1 h, prehybridized
in hybridization buffer (63 SSC, 50 mM sodium phos-hate, pH 6.8, 103 Denhardt’s solution, 2% SDS, 50
mg/ml salmon testis DNA) at 65°C for 4 h and then
f
chybridized with a 32P-labeled PstI–KpnI fragment of
pSTY-09 overnight at 65°C. After hybridization, the mem-
brane was washed with 53 SSC–0.1% SDS three times at
65°C, with 23 SSC–0.1% SDS three times at 65°C, and
then with 0.13 SSC–0.1% SDS at room temperature three
times. Membranes were covered with Saran wrap and
exposed to X-ray film.
RT–PCR
For RT–PCR analysis, poly(A)1 RNA was purified from
the total RNA extracted as above using Oligotex-dT Su-
per (Takara, Kyoto, Japan), and the first-strand cDNA was
synthesized using the SuperScript preamplification sys-
tem (GIBCO BRL), with an oligo(dT) primer, according to
the manufacturer’s instruction. The primer pair was 59-
GAATGTCGAGCTCTAGACAG-39 (forward primer) and 59-
CCCGATTGCACCATCTGTTG-39 (reverse primer). PCR
was performed in the presence of 200 nM primers, 200
mM dNTPs, and 1 U of polymerase from the Expand High
Fidelity PCR system (Boehringer-Mannheim Biochemi-
cals) in the buffer with 1.5 mM MgCl2 supplied by the
anufacturer.
After an initial denaturation of 5 min at 95°C, a thermal
ycle of 30 s at 95°C, 30 s at 55°C, and 1 min at 72°C
as repeated 35 times.
NA sequencing
For the sequencing of the cDNA inserts in pGAD424,
ynthetic oligonucleotides (17-mers) were 59 end-labeled
ith IRD41 (Aloka). The sequences of the primers were
9-TACCACTACAATGGATG-39 (forward direction) and 59-
AGATGGTGCACGATGC-39 (reverse direction). Se-
uencing was performed using a SequiTherm Long-
ead cycle sequencing kit (Epicenter Technologies,
adison, WI) based on the dideoxynucleotide termina-
ion method and analyzed on a 4000L DNA sequencer
LI-COR, Inc). The results of DNA sequencing were ana-
yzed using Mac DNASIS software.
estern blotting
Protein samples were separated by SDS–PAGE in 10%
crylamide and electrophoretically transferred to a PVDF
embrane (Bio-Rad, Hercules, CA). Standard prestained
olecular weight markers (Bio-Rad) were included in
arallel lanes. The PVDF membranes were treated over-
ight at 4°C with blocking buffer (PBS containing 0.1%
ween 20 and 5% skim milk) and reacted for 1 h at room
emperature with antibody diluted 200-fold with blocking
uffer. The membranes were washed with PBS contain-
ng 0.1% Tween 20 (PBS-T) five times and finally incu-
ated for another hour with POD-conjugated goat anti-
abbit antibody (Amersham). After washing with PBS-T
ive times, bound antibodies were detected by enhanced
hemiluminescence reagents (ECL; Amersham).
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318 TANIGUCHI ET AL.Transfection
The day before transfection, COS-7 or 293T cells were
plated onto 60-mm dishes at 5 3 105 cells/dish. Trans-
ection experiments were performed using SuperFect
Qiagen, Studio City, CA) according to the manufacturer’s
nstructions. Transfected cells were harvested 48 h after
ransfection and processed for an immunofluorescence
ssay or SDS–PAGE.
ndirect immunofluorescence assay
The monoclonal antibody PML (PG-M3) was used to
etect ND-10 (Santa Cruz Biotechnology, Santa Cruz,
A). Mouse monoclonal antibodies against DNA poly-
erase processivity factor (U27) and Major DNA binding
rotein (U41) were made in this laboratory (unpublished
ata). Mouse monoclonal antibodies were used at 1
mg/ml, and rabbit polyclonal antibodies were used at
1:400 dilution.
Cells were collected, washed with PBS, spotted onto
slide glasses, air dried, and fixed in cold acetone for 10
min. Fixed cells were incubated with appropriately di-
luted primary antibodies for 60 min at room temperature
in a humid chamber. After incubation, slides were
washed with PBS three times and incubated with an
FITC-conjugated anti-rabbit antibody (DAKO, Carpinteria,
CA) and/or rhodamine-conjugated anti-mouse antibody
(Cappel Laboratories, Durham, NC) for an additional 60
min at room temperature. After washing with PBS, slides
were mounted with 90% (vol/vol) glycerol in PBS and
examined using laser scanning microscopy (Zeiss).
Construction of expression plasmids
cDNA clones containing the full-length transcript of
U79-80 were digested with NotI, and the fragments were
fractionated by agarose gel electrophoresis. Inserts
were purified from the agarose gel using GENECLEAN III
(Bio 101, Vista, CA) and recloned into the NotI site of
pcDNA 3.1 (Invitrogen, San Diego, CA) under the control
of the HCMV IE promoter.
In vitro transcription/translation
The cDNA clones inserted into pcDNA3.1 were tran-
scribed and translated using the TNT T7 Quick Coupled
ranslation/Transcription system (Promega, Madison,
I) in the presence of 10 mCi of [35S]methionine, accord-
ing to the manufacturer’s instruction. The translated
products were fractionated by SDS–PAGE and detected
using fluorography.
59 RACE
59 RACE was performed using a cDNA ends amplifi-
1cation kit (GIBCO BRL) and poly(A) RNA extracted from
HHV-6-infected MT-4 cells at 24 h p.i. The first-strandcDNA of the 59 RACE was synthesized using a U79-80-
specific primer (GSP-1; 59-CTGTCTAGAGCTCGACATTC-
39) and tailed with dCTP. The cDNA was amplified by
PCR using an adapter-specific primer provided in the kit
and a second primer (GSP-2; 59-CCCAATATCCACCGTTA-
GAG-39). 59 RACE cDNA PCR products were inserted into
the pCR2.1 vector (Invitrogen) according to the manufac-
turer’s instruction and sequenced. The TA clones of the
59 RACE PCR products were sequenced as described
above.
Nuclear-cytoplasmic fractionation
HHV-6-infected MT-4 cells were harvested at 48 h p.i.
and washed twice with PBS. The cell pellet was sus-
pended in 100 ml of lysis buffer (50 mM Tris–Cl, pH 7.6,
25 mM KCl, 3.5 mM CaCl2, 5 mM MgCl2, 0.5 mM EDTA,
1 mM DTT, 0.5% Nonidet P-40, 0.5% sodium deoxy-
cholate) and incubated on ice for 10 min. The nuclei were
pelleted by centrifugation at 500 g for 10 min at 4°C. The
supernatant cytoplasmic fraction was recovered. The
nuclear pellet was washed again with 500 ml of lysis
uffer and pelleted as above. The cytoplasmic fraction
as mixed with an equal volume of 23 SDS–PAGE sam-
le buffer, and the nuclear pellet was suspended in 13
DS–PAGE sample buffer. Both samples were heated at
00°C for 5 min.
adiolabeling of infected cell proteins and
mmunoprecipitation
For 35S-methionine labeling, HHV-6-infected or mock-
nfected MT-4 cells were washed twice with PBS at 18 h
.i. and incubated for 60 min with methionine-free RPMI
640 (Sigma Chemical Co., St. Louis, MO) containing 10%
ialyzed FBS (Sigma). The medium was replaced with
ethionine-free RPMI 1640 containing 10% dialyzed FBS
nd 200 mCi of [35S]methionine (Amersham). The cells
ere then cultured for an additional 6 h. For 32P labeling,
HV-6-infected or mock-infected MT-4 cells were
ashed twice with PBS at 18 h p.i. and incubated for 60
in with phosphate-free RPMI 1640 (GIBCO BRL) con-
aining 10% dialyzed FBS. The medium was replaced
ith phosphate-free RPMI 1640 containing 10% dialyzed
BS and 1 mCi of [32P]orthophosphate (Amersham) and
hen cultured for an additional 6 h as for 35S-methionine
abeling. The cells were harvested after labeling and
ashed three times with PBS. The cell pellet was dis-
olved in 0.5 ml of SDS–lysis buffer (0.5% SDS, 50 mM
ris–Cl, pH 8.0, 1 mM DTT), heated at 100°C for 5 min,
nd then mixed with 4 volumes of RIPA correction buffer
1.25% Nonidet P-40, 1.25% sodium deoxycholate, 10 mM
ris–Cl, pH 7.4, 150 mM NaCl, 2 mM EDTA, and 100mg/ml PMSF). Cell lysates were clarified by centrifuga-
tion in an Eppendorf centrifuge for 30 min at 4°C.
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319ANALYSIS OF U79-80 GENE OF HHV-6Cleared lysates were used directly for immunoprecipita-
tion or stored at 270°C.
Radiolabeled lysates (1.0 ml) were precleared by add-
ing 50 ml of 20% protein G–Sepharose FF (Pharmacia)
uspension and incubating them at 4°C for 1 h. The
ysates were spun at 4°C for 2 min in an Eppendorf
entrifuge, and the pellets were discarded. Five microli-
ers of immune rabbit serum was added to the pre-
leared lysates, which were then incubated at 4°C for
h. After incubation, 50 ml of 20% protein G–Sepharose
FF suspension was added, and the lysates were incu-
bated at 4°C for an additional 16 h. Immune complexes
were collected by centrifugation as above and washed
five times with RIPA buffer (1% Nonidet P-40, 1% sodium
deoxycholate, 10 mM Tris–Cl, pH 7.4, 150 mM NaCl, 2
mM EDTA, and 100 mg/ml PMSF), suspended in SDS-
ample buffer, and heated at 100°C for 5 min. Immuno-
recipitated samples were fractionated by SDS–PAGE.
fter electrophoresis, 35S-labeled gels were soaked in
NH3ANCE (New England Nuclear, Boston, MA) and
ried under vacuum. Dried gels were fluorographed at
70°C except for the 32P-labeled gel, which was sub-
jected to autoradiography at 270°C.
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